TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $7,121 | -74.8% | 21,019 | -50.0% | 0.00% | – |
Q4 2022 | $28,292 | +23.0% | 42,038 | +100.0% | 0.00% | – |
Q3 2022 | $23,000 | -11.5% | 21,019 | 0.0% | 0.00% | – |
Q2 2022 | $26,000 | -57.4% | 21,019 | 0.0% | 0.00% | – |
Q1 2022 | $61,000 | +17.3% | 21,019 | +2.0% | 0.00% | – |
Q4 2021 | $52,000 | -16.1% | 20,600 | 0.0% | 0.00% | – |
Q3 2021 | $62,000 | – | 20,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
One68 Global Capital, LLC | 30,120 | $10,196 | 0.02% |
SHEETS SMITH WEALTH MANAGEMENT | 60,000 | $20,310 | 0.00% |
Warberg Asset Management LLC | 20,000 | $6,770 | 0.00% |
Shay Capital LLC | 15,060 | $5,098 | 0.00% |
WELLS FARGO & COMPANY/MN | 51 | $17 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 75,683 | $25,641 | 0.00% |
STATE STREET CORP | 21,019 | $7,121 | 0.00% |
GOLDMAN SACHS GROUP INC | 13,122 | $4,442 | 0.00% |
BlackRock Inc. | 1,385 | $469 | 0.00% |